NOTCH2NLC Gene

NOTCH2NLC Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NOTCH2NLC Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>NOTCH2NLC</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Notch 2 N-terminal-like protein</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>100302521</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000237289</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9P0M4</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>2,451 bp</td>
</tr>
</table>

NOTCH2NLC (Notch 2 N-terminal-like protein) is a gene located on chromosome 1q12 that encodes a protein member of the Notch receptor family. The gene harbors a GGC repeat in its 5'UTR region, and pathogenic expansions of this repeat cause neuronal intranuclear inclusion disease (NIID) and have been associated with other neurodegenerative disorders including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [frontotemporal dementia](/diseases/frontotemporal-dementia), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)[@ishizuka2019].

NOTCH2NLC Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NOTCH2NLC Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>NOTCH2NLC</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Notch 2 N-terminal-like protein</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>100302521</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000237289</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9P0M4</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>2,451 bp</td>
</tr>
</table>

NOTCH2NLC (Notch 2 N-terminal-like protein) is a gene located on chromosome 1q12 that encodes a protein member of the Notch receptor family. The gene harbors a GGC repeat in its 5'UTR region, and pathogenic expansions of this repeat cause neuronal intranuclear inclusion disease (NIID) and have been associated with other neurodegenerative disorders including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [frontotemporal dementia](/diseases/frontotemporal-dementia), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)[@ishizuka2019].

NOTCH2NLC represents a critical example of a non-coding repeat expansion disorder, where the pathogenic mechanism involves RNA toxicity rather than protein aggregation. The discovery of NOTCH2NLC repeat expansions has opened new avenues for understanding neurodegeneration and developing therapeutic interventions[@sone2020].

Gene Information

Protein Structure and Function

Protein Domains

The NOTCH2NLC protein contains several key structural features:

• N-terminal signal peptide: Directs protein trafficking to the cell membrane
• Epidermal growth factor-like (EGF) repeats: Multiple EGF repeats in the extracellular domain, characteristic of Notch family receptors, mediate ligand binding and protein-protein interactions[@okamoto2019]
• Notch repeat (NR) domain: Specific to Notch-like proteins
• Transmembrane domain: Spans the cell membrane
• C-terminal intracellular domain: Contains transcriptional activation domains (although NOTCH2NLC is considered a pseudogene that may not produce a functional protein)

Normal Function

In the normal nervous system, Notch signaling regulates critical processes:

• Neuronal development: Controls neurogenesis, gliogenesis, and neuronal differentiation during development and in adult neurogenic niches[@tian2021]
• Synaptic plasticity: Modulates learning and memory processes through activity-dependent signaling
• Astrocyte function: Regulates astrocyte reactivity and the neuroinflammatory response
• Neural stem cell maintenance: Supports the pool of neural stem cells in the subventricular zone and hippocampus
• Cell fate decisions: Determines whether progenitor cells differentiate into neurons or glia

Molecular Mechanism of Disease

GGC Repeat Expansion Pathogenesis

The pathogenic mechanism in NOTCH2NLC-associated diseases involves a toxic gain-of-function through RNA-mediated mechanisms:

RNA Foci Formation

Expanded GGC repeats in the 5'UTR of NOTCH2NLC are transcribed into RNA that forms abnormal nuclear RNA foci. These foci sequester important RNA-binding proteins, disrupting normal RNA metabolism:

• MBNL1 sequestration: Muscleblind-like 1 protein (MBNL1), a key regulator of alternative splicing, is sequestered into RNA foci, leading to misregulation of thousands of alternative splicing events[@mori2019]
• CELF1 dysregulation: Another RNA-binding protein affected by foci formation
• Nuclear import/export disruption: RNA processing and transport are impaired
• Translation dysregulation: The expanded 5'UTR affects translation initiation

Downstream Effects

The RNA toxicity leads to multiple downstream pathological changes:

Genotype-Phenotype Correlation

The number of GGC repeats correlates with disease phenotype and severity:

• Normal: 5-38 repeats
• Intermediate (reduced penetrance): 38-100 repeats
• Full penetrance: >100 repeats
• Juvenile onset: Often >200 repeats[@gao2020]

Disease Associations

Neuronal Intranuclear Inclusion Disease (NIID)

NIID is a progressive neurodegenerative disorder characterized by[@fan2020]:

• Intranuclear inclusions: eosinophilic inclusions in [neurons](/entities/neurons) and glial cells throughout the nervous system
• Progressive encephalopathy: Decline in cognitive function, movement, and behavior
• Clinical manifestations:
• Dementia (most common presentation)
• Parkinsonism (rigidity, bradykinesia, tremor)
• Cerebellar ataxia (coordination difficulties)
• Peripheral neuropathy
• Autonomic dysfunction
• Epilepsy

Frontotemporal Dementia (FTD)

Repeat expansions in NOTCH2NLC have been implicated in[@inoue2021]:

• Behavioral variant FTD
• Primary progressive aphasia
• FTD-motor neuron disease spectrum

Amyotrophic Lateral Sclerosis (ALS)

Some patients with NOTCH2NLC expansions present with ALS-like features:

• Progressive muscle weakness
• Spasticity
• Bulbar dysfunction
• Respiratory failure

Alzheimer's Disease

Evidence suggests NOTCH2NLC may play a role in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

• The Notch signaling pathway interacts with [amyloid precursor protein](/entities/app-protein) (APP) processing
• Notch and APP share common processing pathways (gamma-secretase cleavage)
• Altered Notch signaling may affect amyloid deposition and neuronal survival
• Some studies have identified NOTCH2NLC repeat expansions in AD patients

Parkinson's Disease

Potential links to [Parkinson's disease](/diseases/parkinsons-disease):

• Some patients with NIID present with parkinsonian features
• Notch signaling affects dopaminergic neuron survival
• Potential interaction with alpha-synuclein pathology

Essential Tremor

Strong association between NOTCH2NLC repeat expansions and essential tremor[@fan2020]:

• Up to 20% of essential tremor cases may harbor expansions
• May represent an intermediate phenotype between ET and NIID
• Suggests a continuum of NOTCH2NLC-related disorders

Expression Patterns

NOTCH2NLC is expressed in multiple tissue types:

Brain Regions

• Cerebral cortex: High expression in pyramidal neurons
• Hippocampus: Particularly in CA1 and CA3 regions
• Basal ganglia: Including striatum and substantia nigra
• Cerebellum: Purkinje cells show expression
• Subventricular zone: Neural stem cell niche

Cell Types

• Neurons: Both excitatory (glutamatergic) and inhibitory (GABAergic) neurons
• [Astrocytes](/entities/astrocytes): Expression in astrocytic populations
• Oligodendrocytes: Myelinating glial cells
• Neural progenitor cells: During development and adult neurogenesis

Peripheral Tissues

• Peripheral blood mononuclear cells
• Skin fibroblasts
• Muscle

Diagnostic Features

Genetic Testing

• PCR-based repeat expansion detection: Standard method for diagnosing repeat expansions
• Southern blotting: Determines exact repeat number
• Next-generation sequencing: Long-read sequencing can detect expansions directly[@sone2020]

Neuroimaging Findings

• MRI: May show white matter abnormalities, cerebral atrophy
• PET: Reduced glucose metabolism in affected regions
• DWI: Characteristic high-signal lesions in some cases

Neuropathology

• p62-positive intranuclear inclusions: Ubiquitinated protein aggregates
• RNA foci: Detectable by RNA-FISH
• Neuronal loss: Variable depending on region
• Gliosis: Reactive astrocytosis

Therapeutic Approaches

Antisense Oligonucleotide Therapy

Current research focuses on ASO-based approaches[@chen2023]:

• ASOs targeting repeat RNA: Reduce RNA foci formation
• Allele-specific ASOs: Target expanded allele specifically
• Splice-modulating ASOs: Restore normal splicing patterns
• Delivery methods: Intrathecal, intravenous, or direct CNS delivery

Small Molecule Approaches

• RNA-binding protein modulators: Compounds that prevent protein sequestration
• Nuclear export inhibitors: May reduce RNA toxicity
• Proteostasis enhancers: Support protein quality control pathways

Gene Therapy

• Gene silencing: CRISPR-based approaches to reduce mutant allele expression
• Gene replacement: Not applicable as NOTCH2NLC loss-of-function is not pathogenic
• Base editing: Potential to contract repeat expansions

Symptomatic Treatments

• Cognitive enhancers: Cholinesterase inhibitors
• Movement disorder treatments: Levodopa for parkinsonism
• Anticonvulsants: For seizure control
• Physical therapy: Maintain function and mobility

Epigenetic Mechanisms

DNA Methylation

Repeat expansions can affect epigenetic regulation:

• Methylation changes: Altered DNA methylation at expanded loci
• Transcription interference: Methylation of promoter regions
• Imprinting effects: Potential parent-of-origin effects

Histone Modifications

Chromatin states are dysregulated:

• Reduced H3K27ac: Associated with transcriptional changes
• Increased repressive marks: Altered heterochromatin
• Enhancer activity: Effects on downstream gene regulation

Long Non-coding RNAs

The repeat region may produce toxic lncRNAs:

• Focal transcripts: RNA from expanded repeat region
• Bidirectional transcription: Sense and antisense transcripts
• Splice isoform changes: Aberrant splicing patterns

Animal Models

Transgenic Models

Animal models have been developed to study NOTCH2NLC pathogenesis:

• GGC repeat knock-in mice: Model reproduces key features
• Brain-specific expression: Targeted to neuronal populations
• RNA foci formation: Detectable in affected tissues
• Behavioral phenotypes: Motor and cognitive deficits

Phenotypic Findings

Animal models reveal:

• Progressive decline: Age-dependent worsening
• RNA foci in neurons: Sequestration of MBNL1
• Splicing alterations: Similar to human disease
• Therapeutic testing: ASO response in models

Research Directions

Biomarker Development

• Repeat size correlation: Establish clear genotype-phenotype relationships
• Biofluid markers: Detect expansion status in blood or CSF
• Imaging biomarkers: Characteristic patterns on MRI/DWI
• Skin biopsy: Detect RNA foci in dermal cells

Understanding Pathogenesis

• RNA toxicity mechanisms: Further characterize RNA foci biology
• Protein interactions: Identify proteins sequestered in foci
• Cellular models: Develop better in vitro and in vivo models
• Proteostasis: Effects on protein quality control

Clinical Trials

• ASO clinical trials: Planned for coming years
• Natural history studies: Characterize disease progression
• Endpoint development: Define meaningful outcome measures
• Patient registries: Global coordination efforts

Key Publications

See Also

• [Neuronal Intranuclear Inclusion Disease](/diseases/neuronal-intranuclear-inclusion-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Notch Signaling Pathway](/mechanisms/notch-signaling-pathway)
• [Repeat Expansion Disorders](/mechanisms/repeat-expansion-disorders)

External Links

• [NCBI Gene: NOTCH2NLC](https://www.ncbi.nlm.nih.gov/gene/100302521)
• [Ensembl: ENSG00000237289](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000237289)
• [UniProt: Q9P0M4](https://www.uniprot.org/uniprot/Q9P0M4)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving NOTCH2NLC Gene discovered through SciDEX knowledge graph analysis: